Adenosine A2A receptor activators and endotoxin together increase VEGF production in immune cells through low-oxygen response control
Updated
Abstract
Adenosine A2A receptor (A2AR) agonists and the TLR4 agonist LPS may synergistically enhance macrophage VEGF expression.
- TLR4 agonist LPS and A2AR agonists NECA and CGS21680 increase VEGF transcription in macrophages.
- The hypoxia response element (HRE) in the VEGF promoter is critical for the transcriptional activation observed.
- LPS treatment raises HIF-1alpha mRNA levels through an NF-kappaB-dependent mechanism, while NECA increases these levels via an A2AR-dependent pathway.
- LPS can induce luciferase expression from a HIF-1alpha promoter independently of A2AR.
- The increase in HIF-1alpha mRNA due to NECA appears to occur after transcription, suggesting a post-transcriptional regulatory mechanism.
- Deletion of NF-kappaB-binding sites from the VEGF promoter does not alter VEGF promoter activity, indicating NF-kappaB's indirect role in VEGF transcription.
Simplified